Section Arrow
Quote
ZTS.NYSE
- ZOETIS
Quotes are at least 15-min delayed:2025/05/10 19:33 EDT
Last
 159.27
-2.42 (-1.50%)
Day High 
162.435 
Prev. Close
161.69 
1-M High
162.16 
Volume 
4.24M 
Bid
155.98
Ask
161.5
Day Low
159.08 
Open
161.41 
1-M Low
139.7 
Market Cap 
72.12B 
Currency USD 
P/E 29.03 
%Yield 1.17 
10-SMA 155.76 
20-SMA 152.48 
50-SMA 158.59 
52-W High 200.33 
52-W Low 139.7 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
5.57/6.83
Enterprise Value
77.52B
Balance Sheet
Book Value Per Share
10.46
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
9.26B
Operating Revenue Per Share
18.77
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed：2025/05/10 19:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.